<DOC>
	<DOCNO>NCT01820715</DOCNO>
	<brief_summary>A multi-centers , placebo-controlled , randomize , double-blinded , pilot clinical trial design evaluate safety DA-3030 injection explore efficacy Neuropathic pain .</brief_summary>
	<brief_title>A Study Evaluate Safety DA-3030 Explore Efficacy Diabetic Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>20≤ Age ≤ 70 Diagnosed Type I Type II diabetes HbA1c ≤ 11 % Patients diabetic neuropathic pain least 3 month Patients corresponding average pain level 4 point mor 24 hour evaluate 11point Likert scale Neuropathic pain due cause Another strong pain neuropathic pain Abnormality blood pressure , weight Positive reaction HIV , HBV HCV A medical history mental illness within 6 month The grade BDI ( Beck Depression Inventory ) exceed 21 point History drug/alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>